AI was one of the big themes for SPACs in 2023. Now in 2024, investor appetite and the market opportunity around AI is just as strong.
This week, we speak with Michael Zacharski, CEO of BEN and Chris Gaertner, Co-CEO and CFO of DHC Acquisition Corp. (Nasdaq: DHCA). The two announced a $358 million combination in September.
Michael explains how BEN has built an AI customer engagement tool focused on the auto sales and health care spaces and why those sectors were particularly ripe for disruption.
Chris describes DHC’s process in pulling together a PIPE with strategic investment in a difficult market and how the SPAC is further supporting the transaction through to close.
Both also touch on why they welcome increased scrutiny towards how companies going public describe their AI technologies, or lack thereof.
Give it a listen
Terms Tracker for the Week Ending May 3, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. The big news this week was that SPACs finally had a new IPO price with Churchill Capital Corp. IX’s $250 million offering on Thursday. SPACs...
Real estate marketplace Opendoor (NASDAQ:OPEN) is poised to be the latest de-SPAC to take a double-digit jump on earnings as it heads towards the weekend up +10%, having spiked as high as +27% earlier in the day. The movement comes as the former Social Capital II target reported progress towards profitability despite a high rates...
At the SPAC of Dawn Coinbase (NASDAQ:COIN) notched a surprise profit of over $1.5 billion in the first quarter of 2024, well exceeding estimates, demonstrating the powerful effect of publicly traded ETFs have had on crypto marketplaces since the start of the year. The result has pushed the company to bump up its own guidance...
Online casino and sports company Rush Street (NYSE:RSI) is up +18.4% in trading today on the back of a solid first quarter earnings release, bringing the company’s stock to its highest price since the second half of 2022 (currently $7.60). This makes it the latest in a line of 2020 and 2021 de-SPACs that have...
Mountain Crest V (NASDAQ:MCAG) broke a long dealmaking silence by SPACs this morning, albeit with a non-binding agreement to combine with Seoul-based diagnostic biotech firm CUBEBIO. The term sheet would give the company a $620 million pre-transaction equity value and help accelerate the rollout of CUBEBIO’s CEED-NOVUS cancer screening kit products. The company signed an...